Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Citalopram hydrobromide |
Is a |
False |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Citalopram poisoning |
Causative agent (attribute) |
True |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental citalopram poisoning |
Causative agent (attribute) |
False |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional citalopram poisoning |
Causative agent (attribute) |
False |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication par le citalopram d'intention indéterminée |
Causative agent (attribute) |
False |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Citalopram adverse reaction |
Causative agent (attribute) |
True |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Citalopram allergy |
Causative agent (attribute) |
False |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Citalopram overdose (disorder) |
Causative agent (attribute) |
True |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental citalopram overdose |
Causative agent (attribute) |
True |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional citalopram overdose (disorder) |
Causative agent (attribute) |
True |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose de citalopram d'intention indéterminée |
Causative agent (attribute) |
False |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing citalopram (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Citalopram (as citalopram hydrobromide) 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely citalopram (as citalopram hydrobromide) 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Citalopram (as citalopram hydrobromide) 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely citalopram (as citalopram hydrochloride) 40 milligram/1 milliliter conventional release oral drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental citalopram poisoning |
Causative agent (attribute) |
True |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional citalopram poisoning |
Causative agent (attribute) |
True |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely citalopram (as citalopram hydrobromide) 10 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Citalopram (as citalopram hydrobromide) 20 mg orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely citalopram (as citalopram hydrobromide) 40 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Citalopram hydrochloride (substance) |
Is a |
False |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Citalopram allergy |
Causative agent (attribute) |
True |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Citalopram (as citalopram hydrobromide) 20 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely citalopram (as citalopram hydrobromide) 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Citalopram (as citalopram hydrobromide) 40 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Citalopram hydrobromide |
Is modification of (attribute) |
True |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Citalopram hydrochloride (substance) |
Is modification of (attribute) |
True |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Citalopram-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely citalopram (as citalopram hydrochloride) 40 milligram/1 milliliter conventional release oral drops (clinical drug) |
Has basis of strength substance (attribute) |
True |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Citalopram only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Citalopram only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely citalopram (as citalopram hydrobromide) 10 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely citalopram (as citalopram hydrobromide) 40 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Citalopram (as citalopram hydrobromide) 20 mg orodispersible tablet |
Has basis of strength substance (attribute) |
True |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Citalopram (as citalopram hydrobromide) 2 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Citalopram only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing citalopram in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely citalopram (as citalopram hydrobromide) 30 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Citalopram (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |